Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
On Monday, August 20, at 10:00 a.m., Global Med's management will give a25-minute presentation regarding Global Med's business and discuss its uniquevalue proposition, latest developments, financial performance and prospects.Management will also participate in a question and answer session followingthe presentation and in one-on-one meetings throughout the day.
Advertisement
The presentation, with streaming video and PowerPoint presentation, willbe webcast live and archived on the websites of Global Med(www.globalmedtech.com), and at Noble Financial's conference website atwww.two-007.net. It is recommended that interested parties register at least15 minutes prior to the start of the presentation to ensure timely access.
About Noble Financial
Noble Financial is a privately-held, full-service capital markets firmdriven by what is often overlooked by other firms -- uncovering the valueembedded in the orphaned, undiscovered or misunderstood company. The companyfocuses on converting market inefficiencies into profit opportunities. NobleFinancial supports emerging companies through strategic advice, investmentbanking, market-making, sales and trading, comprehensive equity research, andthe development of institutional support. This is Noble Financial's thirdequity conference. The company has operated for 23 years and has offices inFlorida and New York City.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medicalinformation technology company providing information management softwareproducts and services to the healthcare industry. Its WyndgateTechnologies(R) division is a leading supplier of information managementsystems to U.S. and international blood centers and hospital transfusioncenters. Each year, Wyndgate's products and services manage more than eightmillion blood components, representing over 27% of the U.S. blood supply.Wyndgate's products are also being used in Canada and sub-Saharan Africa, andare being implemented in the Caribbean. Together, the Donor Doc(TM)interactive donor health history questionnaire, SafeTrace(R) donor managementsystem, and the SafeTrace Tx(R) advanced transfusion management system,recently patented, provide Vein-to-Vein(R) tracking from donor collection topatient transfusion.
For more information about Global Med's products and services, please call800-WYNDGATE or visit www.globalmedtech.com, www.peoplemed.com andwww.wyndgate.com.
This news release may include statements that constitute forward-lookingstatements, usually containing the words "believe," "estimate," "project,""expects" or similar expressions. These statements are made pursuant to thesafe harbor provisions of the Private Securities Litigation Reform Act of1995. Forward-looking statements inherently involve risks and uncertaintiesthat could cause actual results to differ materially from the forward-lookingstatements. By making these forward-looking statements, the Companyundertakes no obligation to update these statements for revisions or changesafter the date of this news release.
SOURCE Global Med Technologies, Inc.
